DOCSLIB.ORG

Vitamin K Epoxide Reductase Prefers ER Membrane- Anchored Thioredoxin-Like Redox Partners

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vitamin K Epoxide Reductase Prefers ER Membrane- Anchored Thioredoxin-Like Redox Partners Vitamin K epoxide reductase prefers ER membrane- anchored thioredoxin-like redox partners Sol Schulman, Belinda Wang, Weikai Li, and Tom A. Rapoport1 Howard Hughes Medical Institute and Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115 Contributed by Tom A. Rapoport, July 11, 2010 (sent for review May 17, 2010) Vitamin K epoxide reductase (VKOR) sustains blood coagulation of this reaction (9). In a first step (Fig. 1A), the reduced CXXC by reducing vitamin K epoxide to the hydroquinone, an essential motif of the Trx-like protein domain transfers electrons to two cofactor for the γ-glutamyl carboxylation of many clotting factors. conserved cysteines in a periplasmic loop of VKOR (Fig. S1); this The physiological redox partner of VKOR remains uncertain, but is loop is located between transmembrane (TM) segments 1 and 2 likely a thioredoxin-like protein. Here, we demonstrate that human of the four-TM bundle surrounding the quinone. The reaction VKOR has the same membrane topology as the enzyme from proceeds through a mixed disulfide bridge intermediate, in which Synechococcus sp., whose crystal structure was recently deter- the N-terminal cysteine in the CXXC motif of the Trx-like mined. Our results suggest that, during the redox reaction, domain is linked with the N-terminal loop cysteine in VKOR Cys43 in a luminal loop of human VKOR forms a transient disulfide (Fig. 1A; boxed intermediate). This mixed disulfide bridge is sub- bond with a thioredoxin (Trx)-like protein located in the lumen of sequently resolved by attack of the C-terminal cysteine in the the endoplasmic reticulum (ER). We screened for redox partners of CXXC motif of the Trx-like domain, resulting in its oxidation with VKOR among the large number of mammalian Trx-like ER proteins concomitant reduction of the VKOR loop cysteines. In the next by testing a panel of these candidates for their ability to form this step, the electrons are transferred from the loop cysteines to a specific disulfide bond with human VKOR. Our results show that CXXC motif at the periplasmic edge of the fourth TM of VKOR VKOR interacts strongly with TMX, an ER membrane-anchored (Fig. 1A). Finally, the disulfide bridge in the CXXC motif Trx-like protein with a unique CPAC active site. Weaker interactions of VKOR is regenerated by transfer of electrons to vitamin K. were observed with TMX4, a close relative of TMX, and ERp18, the The hydroquinone leaves into the lipid phase and is reoxidized smallest Trx-like protein of the ER. We performed a similar screen by the electron transfer chain. with Ero1-α, an ER-luminal protein that oxidizes the Trx-like protein A similar reaction mechanism has been proposed for the mam- disulfide isomerase. We found that Ero1-α interacts with most of malian VKOR, with a Trx-like protein in the ER lumen serving as the tested Trx-like proteins, although only poorly with the mem- its redox partner (4, 5, 9). However, conflicting topology models brane-anchored members of the family. Taken together, our results with three or four TM segments have been proposed for human demonstrate that human VKOR employs the same electron VKOR (6, 9, 11); the loop cysteines interacting with the Trx-like transfer pathway as its bacterial homologs and that VKORs gener- protein would thus be on either the cytosolic or luminal side of ally prefer membrane-bound Trx-like redox partners. the ER membrane. In addition, both the cytosolic thioredoxin protein and the luminal PDI protein have been shown to support disulfide bond formation ∣ warfarin ∣ quinone ∣ blood coagulation ∣ the VKOR reaction in vitro (4, 5, 12, 13). The recent crystal struc- electron transfer ture of a bacterial VKOR homolog and multiple sequence align- ments suggest that the mammalian VKORs may also conform to itamin K epoxide reductase (VKOR) is a crucial enzyme in a four-TM model, which would necessitate an ER-luminal redox Vblood coagulation and the target of the most commonly used partner (6, 9). However, there are many potential redox partners, oral anticoagulant warfarin. VKOR catalyzes the reductive as the mammalian ER contains 20 proteins with a Trx-like fold, 12 branch of the vitamin K cycle (for review, see refs. 1 and 2). of which also have at least one CXXC motif (for review, see The cycle begins with the vitamin K-dependent γ-glutamyl ref. 14). The most abundant and best-studied member of this carboxylase modifying select glutamate residues in blood-clotting family is PDI, which is a major catalyst of disulfide bridge forma- factors, a modification required for their activation at sites of tion in newly synthesized secretory and membrane proteins. After tissue injury (for review, see ref. 3). During the carboxylation donating its disulfide bridge to a substrate, PDI is reoxidized by Ero1-α, an ER-luminal protein that uses FAD and molecular reaction, vitamin K hydroquinone is converted to the epoxide – form, and VKOR is needed to regenerate the hydroquinone, thus oxygen in the reaction (15 17). Another member of the ER completing the cycle. The VKOR reaction requires cooperation family of Trx-like proteins, ERp57, has been implicated in the with a redox partner that delivers reducing equivalents. The redox oxidation of glycosylated substrates maintained in the calnexin/ calreticulin folding cycle (18). Conflicting results exist on whether partner remains uncertain, although protein disulfide isomerase α – (PDI), a thioredoxin (Trx)-like protein in the endoplasmic reticu- ERp57 is reoxidized by Ero1- as well (19 21). Although some lum (ER) lumen, has been proposed to serve this role (4, 5). of the other Trx-like ER proteins have been characterized with Homologs of VKOR have been identified in many organisms, respect to redox potential and possible substrates, their biological even species that do not have blood (6–8). These include several functions and physiological oxidants remain unknown. classes of bacteria in which these enzymes are involved in disul- Here, we demonstrate that the human VKOR indeed contains four TM segments, indicating that it interacts with an ER-luminal fide bridge formation of newly synthesized secretory proteins BIOCHEMISTRY (7–10). The reduced cysteines of exported proteins are initially redox partner. To identify this partner, we screened a panel oxidized by a Trx-like protein in the periplasm, leading to the of ER-luminal Trx-like proteins for their ability to form a key reduction of the disulfide bridge in the active site CXXC motif of the Trx-like protein. VKOR then couples the reoxidation of the Author contributions: S.S., B.W., and W.L. performed research; S.S., B.W., W.L., and T.A.R. CXXC motif in the Trx-like protein with reduction of a quinone, analyzed data; and S.S. and T.A.R. wrote the paper. such as vitamin K2 (menaquinone), to the hydroquinone The authors declare no conflict of interest. (Fig. 1A). A recent crystal structure of the VKOR homolog from 1To whom correspondence should be addressed. E-mail: [email protected]. Synechococcus sp., in which the enzyme and a Trx-like domain are This article contains supporting information online at www.pnas.org/lookup/suppl/ contained in a single polypeptide chain, revealed many details doi:10.1073/pnas.1009972107/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1009972107 PNAS ∣ August 24, 2010 ∣ vol. 107 ∣ no. 34 ∣ 15027–15032 Downloaded by guest on September 25, 2021 weight shift. With wild-type VKOR, little modification was ob- served (Fig. 1B, lane 1). However, extensive modification was observed when the ER membrane was solubilized with Triton X-100 (lane 3 versus lane 4), as expected from the presence of multiple endogenous cysteines located inside the ER membrane and in the ER lumen. By contrast, when a cysteine was introduced at the N terminus (Ser3Cys), it was readily modified by Mal-PEG (lane 5), indicating that the N terminus is located in the cytosol. Similar results were obtained with a cysteine introduced at the C terminus (Gly158Cys), consistent with the expectation that it is also located in the cytosol. Control experiments with the lumi- nal ER protein Grp94 showed that its single cysteine can only be modified when the membrane is solubilized by TX-100 (lanes 3, 7, and 11). These data demonstrate that both termini of VKOR are located in the cytosol, supporting a four-TM model for human VKOR and suggesting that the two loop cysteines engage a redox partner located in the ER lumen (Fig. 1B, Right). To identify potential redox partners of human VKOR among the Trx-like proteins of the ER, we exploited a strategy that is based on the established electron transfer pathway in bacteria (9). The correct interaction partners are expected to form a transient mixed disulfide bridge, in which the N-terminal cysteine in the CXXC motif of the Trx-like protein and the N-terminal loop Fig. 1. Electron transfer pathway and membrane topology of human VKOR. cysteine of VKOR (Cys43) are covalently linked (boxed inter- (A) The scheme shows how electrons flow from reduced cysteines in newly mediate in Fig. 1A). This intermediate can be stabilized by mu- synthesized proteins in the ER lumen through a Trx-like protein and VKOR to tating either the C-terminal loop cysteine of VKOR (Cys51Ala), reduce either vitamin K epoxide (KO) to the quinone (K) or the quinone to the C-terminal cysteine in the CXXC motif of the Trx-like pro- the hydroquinone (KH2). The reaction proceeds through the boxed intermediate in which the N-terminal cysteine of the CXXC motif in the tein, or both. These mutations slow the resolution of the mixed Trx-like protein forms a mixed disulfide bond with Cys43 of VKOR.
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Download Download
    Supplementary Figure S1. Results of flow cytometry analysis, performed to estimate CD34 positivity, after immunomagnetic separation in two different experiments. As monoclonal antibody for labeling the sample, the fluorescein isothiocyanate (FITC)- conjugated mouse anti-human CD34 MoAb (Mylteni) was used. Briefly, cell samples were incubated in the presence of the indicated MoAbs, at the proper dilution, in PBS containing 5% FCS and 1% Fc receptor (FcR) blocking reagent (Miltenyi) for 30 min at 4 C. Cells were then washed twice, resuspended with PBS and analyzed by a Coulter Epics XL (Coulter Electronics Inc., Hialeah, FL, USA) flow cytometer. only use Non-commercial 1 Supplementary Table S1. Complete list of the datasets used in this study and their sources. GEO Total samples Geo selected GEO accession of used Platform Reference series in series samples samples GSM142565 GSM142566 GSM142567 GSM142568 GSE6146 HG-U133A 14 8 - GSM142569 GSM142571 GSM142572 GSM142574 GSM51391 GSM51392 GSE2666 HG-U133A 36 4 1 GSM51393 GSM51394 only GSM321583 GSE12803 HG-U133A 20 3 GSM321584 2 GSM321585 use Promyelocytes_1 Promyelocytes_2 Promyelocytes_3 Promyelocytes_4 HG-U133A 8 8 3 GSE64282 Promyelocytes_5 Promyelocytes_6 Promyelocytes_7 Promyelocytes_8 Non-commercial 2 Supplementary Table S2. Chromosomal regions up-regulated in CD34+ samples as identified by the LAP procedure with the two-class statistics coded in the PREDA R package and an FDR threshold of 0.5. Functional enrichment analysis has been performed using DAVID (http://david.abcc.ncifcrf.gov/)
    [Show full text]
  • Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma by Andrea Shergalis
    Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma By Andrea Shergalis A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Medicinal Chemistry) in the University of Michigan 2020 Doctoral Committee: Professor Nouri Neamati, Chair Professor George A. Garcia Professor Peter J. H. Scott Professor Shaomeng Wang Andrea G. Shergalis [email protected] ORCID 0000-0002-1155-1583 © Andrea Shergalis 2020 All Rights Reserved ACKNOWLEDGEMENTS So many people have been involved in bringing this project to life and making this dissertation possible. First, I want to thank my advisor, Prof. Nouri Neamati, for his guidance, encouragement, and patience. Prof. Neamati instilled an enthusiasm in me for science and drug discovery, while allowing me the space to independently explore complex biochemical problems, and I am grateful for his kind and patient mentorship. I also thank my committee members, Profs. George Garcia, Peter Scott, and Shaomeng Wang, for their patience, guidance, and support throughout my graduate career. I am thankful to them for taking time to meet with me and have thoughtful conversations about medicinal chemistry and science in general. From the Neamati lab, I would like to thank so many. First and foremost, I have to thank Shuzo Tamara for being an incredible, kind, and patient teacher and mentor. Shuzo is one of the hardest workers I know. In addition to a strong work ethic, he taught me pretty much everything I know and laid the foundation for the article published as Chapter 3 of this dissertation. The work published in this dissertation really began with the initial identification of PDI as a target by Shili Xu, and I am grateful for his advice and guidance (from afar!).
    [Show full text]
  • Mouse Tmx4 Conditional Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Tmx4 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Tmx4 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Tmx4 gene (NCBI Reference Sequence: NM_029148 ; Ensembl: ENSMUSG00000034723 ) is located on Mouse chromosome 2. 8 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 8 (Transcript: ENSMUST00000038228). Exon 2 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Tmx4 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-20P22 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 2 starts from about 16.42% of the coding region. The knockout of Exon 2 will result in frameshift of the gene. The size of intron 1 for 5'-loxP site insertion: 4004 bp, and the size of intron 2 for 3'-loxP site insertion: 18288 bp. The size of effective cKO region: ~834 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 2 8 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Tmx4 Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • Supplementary Table S2
    1-high in cerebrotropic Gene P-value patients Definition BCHE 2.00E-04 1 Butyrylcholinesterase PLCB2 2.00E-04 -1 Phospholipase C, beta 2 SF3B1 2.00E-04 -1 Splicing factor 3b, subunit 1 BCHE 0.00022 1 Butyrylcholinesterase ZNF721 0.00028 -1 Zinc finger protein 721 GNAI1 0.00044 1 Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 GNAI1 0.00049 1 Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 PDE1B 0.00069 -1 Phosphodiesterase 1B, calmodulin-dependent MCOLN2 0.00085 -1 Mucolipin 2 PGCP 0.00116 1 Plasma glutamate carboxypeptidase TMX4 0.00116 1 Thioredoxin-related transmembrane protein 4 C10orf11 0.00142 1 Chromosome 10 open reading frame 11 TRIM14 0.00156 -1 Tripartite motif-containing 14 APOBEC3D 0.00173 -1 Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D ANXA6 0.00185 -1 Annexin A6 NOS3 0.00209 -1 Nitric oxide synthase 3 SELI 0.00209 -1 Selenoprotein I NYNRIN 0.0023 -1 NYN domain and retroviral integrase containing ANKFY1 0.00253 -1 Ankyrin repeat and FYVE domain containing 1 APOBEC3F 0.00278 -1 Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F EBI2 0.00278 -1 Epstein-Barr virus induced gene 2 ETHE1 0.00278 1 Ethylmalonic encephalopathy 1 PDE7A 0.00278 -1 Phosphodiesterase 7A HLA-DOA 0.00305 -1 Major histocompatibility complex, class II, DO alpha SOX13 0.00305 1 SRY (sex determining region Y)-box 13 ABHD2 3.34E-03 1 Abhydrolase domain containing 2 MOCS2 0.00334 1 Molybdenum cofactor synthesis 2 TTLL6 0.00365 -1 Tubulin tyrosine ligase-like family, member 6 SHANK3 0.00394 -1 SH3 and multiple ankyrin repeat domains 3 ADCY4 0.004 -1 Adenylate cyclase 4 CD3D 0.004 -1 CD3d molecule, delta (CD3-TCR complex) (CD3D), transcript variant 1, mRNA.
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Mutations Suggests Both Loss-Of-Function and Gain-Of-Function Effects Morag A
    © 2021. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2021) 14, dmm047225. doi:10.1242/dmm.047225 RESEARCH ARTICLE Hearing impairment due to Mir183/96/182 mutations suggests both loss-of-function and gain-of-function effects Morag A. Lewis1,2,*, Francesca Di Domenico1, Neil J. Ingham1,2, Haydn M. Prosser2 and Karen P. Steel1,2 ABSTRACT birth. However, this is not the cause of the hearing loss; even before The microRNA miR-96 is important for hearing, as point mutations in the onset of normal hearing, homozygote hair cells fail to mature humans and mice result in dominant progressive hearing loss. Mir96 both morphologically and physiologically, remaining in their is expressed in sensory cells along with Mir182 and Mir183, but the immature state, and heterozygote hair cells show a developmental roles of these closely-linked microRNAs are as yet unknown. Here, delay. miR-96 is thus thought to be responsible for coordinating we analyse mice carrying null alleles of Mir182, and of Mir183 and hair cell maturation (Chen et al., 2014; Kuhn et al., 2011). Mir96 together to investigate their roles in hearing. We found that Overexpression of the three miRNAs also results in cochlear defects Mir183/96 heterozygous mice had normal hearing and homozygotes and hearing loss (Weston et al., 2018). The complete loss of all were completely deaf with abnormal hair cell stereocilia bundles and mature miRNAs from the inner ear results in early developmental reduced numbers of inner hair cell synapses at 4 weeks of age. defects including a severely truncated cochlear duct (Friedman Mir182 knockout mice developed normal hearing then exhibited et al., 2009; Soukup et al., 2009).
    [Show full text]
  • Supplementary Material Contents
    Supplementary Material Contents Immune modulating proteins identified from exosomal samples.....................................................................2 Figure S1: Overlap between exosomal and soluble proteomes.................................................................................... 4 Bacterial strains:..............................................................................................................................................4 Figure S2: Variability between subjects of effects of exosomes on BL21-lux growth.................................................... 5 Figure S3: Early effects of exosomes on growth of BL21 E. coli .................................................................................... 5 Figure S4: Exosomal Lysis............................................................................................................................................ 6 Figure S5: Effect of pH on exosomal action.................................................................................................................. 7 Figure S6: Effect of exosomes on growth of UPEC (pH = 6.5) suspended in exosome-depleted urine supernatant ....... 8 Effective exosomal concentration....................................................................................................................8 Figure S7: Sample constitution for luminometry experiments..................................................................................... 8 Figure S8: Determining effective concentration .........................................................................................................
    [Show full text]
  • Protein Disulfide–Isomerase, a Folding Catalyst and a Redox-Regulated
    Free Radical Biology and Medicine 83 (2015) 305–313 Contents lists available at ScienceDirect Free Radical Biology and Medicine journal homepage: www.elsevier.com/locate/freeradbiomed Protein disulfide–isomerase, a folding catalyst and a redox-regulated chaperone Lei Wang 1, Xi Wang 1, Chih-chen Wang n National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China article info abstract Article history: Protein disulfide–isomerase (PDI) was the first protein-folding catalyst to be characterized, half a century Received 20 November 2014 ago. It plays critical roles in a variety of physiological events by displaying oxidoreductase and redox- Received in revised form regulated chaperone activities. This review provides a brief history of the identification of PDI as both an 4 February 2015 enzyme and a molecular chaperone and of the recent advances in studies on the structure and dynamics Accepted 7 February 2015 of PDI, the substrate binding and release, and the cooperation with its partners to catalyze oxidative Available online 17 February 2015 protein folding and maintain ER redox homeostasis. In this review, we highlight the structural features of Keywords: PDI, including the high interdomain flexibility, the multiple binding sites, the two synergic active sites, Chaperone and the redox-dependent conformational changes. Endoplasmic reticulum & 2015 Elsevier Inc. All rights reserved. Oxidative protein folding Protein conformation Protein disulfide–isomerise Redox regulation Introduction normal biological functions” [4]. The concept of chaperone- assisted protein folding/unfolding/assembly/disassembly, i.e., the Remarkable early work by Hsien Wu [1] and others established “assisted self-assembly” principle, expands the protein folding the first theory of protein denaturation.
    [Show full text]
  • A Concise Review of Human Brain Methylome During Aging and Neurodegenerative Diseases
    BMB Rep. 2019; 52(10): 577-588 BMB www.bmbreports.org Reports Invited Mini Review A concise review of human brain methylome during aging and neurodegenerative diseases Renuka Prasad G & Eek-hoon Jho* Department of Life Science, University of Seoul, Seoul 02504, Korea DNA methylation at CpG sites is an essential epigenetic mark position of carbon in the cytosine within CG dinucleotides that regulates gene expression during mammalian development with resultant formation of 5mC. The symmetrical CG and diseases. Methylome refers to the entire set of methylation dinucleotides are also called as CpG, due to the presence of modifications present in the whole genome. Over the last phosphodiester bond between cytosine and guanine. The several years, an increasing number of reports on brain DNA human genome contains short lengths of DNA (∼1,000 bp) in methylome reported the association between aberrant which CpG is commonly located (∼1 per 10 bp) in methylation and the abnormalities in the expression of critical unmethylated form and referred as CpG islands; they genes known to have critical roles during aging and neuro- commonly overlap with the transcription start sites (TSSs) of degenerative diseases. Consequently, the role of methylation genes. In human DNA, 5mC is present in approximately 1.5% in understanding neurodegenerative diseases has been under of the whole genome and CpG base pairs are 5-fold enriched focus. This review outlines the current knowledge of the human in CpG islands than other regions of the genome (3, 4). CpG brain DNA methylomes during aging and neurodegenerative islands have the following salient features. In the human diseases.
    [Show full text]
  • TMX2) Regulates the Ran Protein Gradient and Importin-Β-Dependent Nuclear Cargo Transport Ami Oguro1,2 & Susumu Imaoka1
    www.nature.com/scientificreports OPEN Thioredoxin-related transmembrane protein 2 (TMX2) regulates the Ran protein gradient and importin-β-dependent nuclear cargo transport Ami Oguro1,2 & Susumu Imaoka1 TMX2 is a thioredoxin family protein, but its functions have not been clarifed. To elucidate the function of TMX2, we explored TMX2-interacting proteins by LC-MS. As a result, importin-β, Ran GTPase (Ran), RanGAP, and RanBP2 were identifed. Importin-β is an adaptor protein which imports cargoes from cytosol to the nucleus, and is exported into the cytosol by interaction with RanGTP. At the cytoplasmic nuclear pore, RanGAP and RanBP2 facilitate hydrolysis of RanGTP to RanGDP and the disassembly of the Ran-importin-β complex, which allows the recycling of importin-β and reentry of Ran into the nucleus. Despite its interaction of TMX2 with importin-β, we showed that TMX2 is not a transport cargo. We found that TMX2 localizes in the outer nuclear membrane with its N-terminus and C-terminus facing the cytoplasm, where it co-localizes with importin-β and Ran. Ran is predominantly distributed in the nucleus, but TMX2 knockdown disrupted the nucleocytoplasmic Ran gradient, and the cysteine 112 residue of Ran was important in its regulation by TMX2. In addition, knockdown of TMX2 suppressed importin-β-mediated transport of protein. These results suggest that TMX2 works as a regulator of protein nuclear transport, and that TMX2 facilitates the nucleocytoplasmic Ran cycle by interaction with nuclear pore proteins. Tioredoxin-related transmembrane proteins (TMXs) are protein disulfde isomerase (PDI) family members and possess a transmembrane region.
    [Show full text]
  • TMX1 Preferentially Acts Upon Transmembrane Polypeptides
    Research Collection Doctoral Thesis In vivo characterization of TMX1: TMX1 preferentially acts upon transmembrane polypeptides Author(s): Brambilla Pisoni, Giorgia Publication Date: 2016 Permanent Link: https://doi.org/10.3929/ethz-a-010665921 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library DISS. ETH NO. 23381 IN VIVO CHARACTERIZATION OF TMX1: TMX1 PREFERENTIALLY ACTS UPON TRANSMEMBRANE POLYPEPTIDES A thesis submitted to attain the degree of DOCTOR OF SCIENCES of ETH ZURICH (Dr. sc. ETH Zurich) presented by GIORGIA BRAMBILLA PISONI Laurea Magistrale in Biologia Molecolare della Cellula, Università degli Studi di Milano born on 08.02.1986 citizen of Italy accepted on the recommendation of Markus Aebi Maurizio Molinari Paola Picotti Roberto Sitia 2016 Parts of this thesis have been published in the following articles: Noack, J., Brambilla Pisoni, G. & Molinari, M. Proteostasis: bad news and good news from the endoplasmic reticulum. Swiss medical weekly 144, w14001, doi:10.4414/smw.2014.14001 (2014). Tannous, A., Brambilla Pisoni, G., Hebert, D. N. & Molinari, M. N-linked sugar-regulated protein folding and quality control in the ER. Seminars in Cell & Developmental Biology 41, 79-89, doi:10.1016/j.semcdb.2014.12.001 (2015). Brambilla Pisoni, G., Ruddock, L. W., Bulleid, N. J. & Molinari, M. Division of labor among oxidoreductases: TMX1 preferentially acts on transmembrane polypeptides. Mol Biol Cell 26(19):3390-400. doi: 10.1091/mbc.E15-05-0321 (2015). Brambilla Pisoni, G. & Molinari, M. Five Questions (with their Answers) on ER-associated Degradation.
    [Show full text]